title: Mechanisms of viral activators.
abstract: Adenovirus large E1A, Epstein-Barr virus Zebra, and herpes simplex virus VP16 were studied as models of animal cell transcriptional activators. Large E1A can activate transcription from a TATA box, a result that leads us to suggest that it interacts with a general transcription factor. Initial studies showed that large E1A binds directly to the TBP subunit of TFIID. However, analysis of multiple E1A and TBP mutants failed to support the significance of this in vitro interaction for the mechanism of activation. Recent studies to be reported elsewhere indicate that conserved region 3 of large E1A, which is required for its activation function, binds to one subunit of a multisubunit protein that stimulates in vitro transcription in response to large E1A and other activators. A method was developed for the rapid purification of TFIID approximately 25,000-fold to near homogeneity from a cell line engineered to express an epitope-tagged form of TBP. Purified TFIID contains 11 major TAFs ranging in mass from approximately 250 to 20 kD. Zta and VP16, but not large E1A, greatly stimulate the rate and extent of assembly of a TFIID-TFIIA complex on promoter DNA (DA complex). For VP16, this is a function of the carboxy-terminal activation subdomain. An excellent correlation was found between the ability of VP16C mutants to stimulate DA complex assembly and their ability to activate transcription in vivo. Consequently, for a subset of activation domains, DA complex assembly activity is an important component of the overall mechanism of activation.
authors.affiliation: Molecular Biology Institute, University of California, Los Angeles 90095-1570, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Berk
authors.forename: T G
authors.initials: TG
authors.lastname: Boyer
authors.forename: A N
authors.initials: AN
authors.lastname: Kapanidis
authors.forename: R H
authors.initials: RH
authors.lastname: Ebright
authors.forename: N N
authors.initials: NN
authors.lastname: Kobayashi
authors.forename: P J
authors.initials: PJ
authors.lastname: Horn
authors.forename: S M
authors.initials: SM
authors.lastname: Sullivan
authors.forename: R
authors.initials: R
authors.lastname: Koop
authors.forename: M A
authors.initials: MA
authors.lastname: Surby
authors.forename: S J
authors.initials: SJ
authors.lastname: Triezenberg
mesh_terms: D017500:Adenovirus E1A Proteins / Q000378:metabolism; D000818:Animals; D004268:DNA-Binding Proteins / Q000378:metabolism; D006367:HeLa Cells; D017405:Herpes Simplex Virus Protein Vmw65 / Q000378:metabolism; D006801:Humans; D015534:Trans-Activators / Q000378:metabolism*; D035362:Transcription Factor TFIID; D014157:Transcription Factors / Q000378:metabolism*; D019473:Transcription Factors, TFII / Q000378:metabolism; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014764:Viral Proteins; D014780:Viruses / Q000235:genetics* / Q000378:metabolism
chemical_list: D017500:Adenovirus E1A Proteins; C063676:BZLF1 protein, Herpesvirus 4, Human; D004268:DNA-Binding Proteins; D017405:Herpes Simplex Virus Protein Vmw65; D015534:Trans-Activators; D035362:Transcription Factor TFIID; D014157:Transcription Factors; D019473:Transcription Factors, TFII; D014764:Viral Proteins